Aspira Pathlab & Diagnostics informs about compliance certificate

10 Apr 2023 Evaluate
Aspira Pathlab & Diagnostics has informed that it enclosed Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, for the quarter ended 31st March, 2023, as received from Link Intime India, the Registrar and Share Transfer Agent (RTA) of the Company.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

68.35 1.60 (2.40%)
05-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7193.05
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1918.30
Aster DM Healthcare 635.10
Global Health 1171.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×